Galderma

🚿🎶 Ducha&Flow x Cetaphil nació de una idea valiente: ¿Qué pasaría si la rutina más íntima del día —la ducha— se convirtiera en un escenario real de expresión, conexión y autocuidado? Hoy, esa idea es una realidad, el pasado 25 de Julio estrenamos un proyecto inigualable, creamos la primera serie musical en el mundo del skincare. 💙 Una campaña sin precedentes en la compañía. 🌍 Un proyecto único que une música, rituales y piel. Invitamos a artistas emergentes Gen Z a cantar desde un estudio ambientado como regadera, y convertimos ese momento personal en contenido emocional y cultural, diseñado para vivir donde ellxs viven: TikTok, Reels, YouTube… y en su día a día. Ducha&Flow x Cetaphil no solo habla de skincare; habla de identidad, de autenticidad, de cómo el cuidado personal también puede sonar. Y eso lo hicimos posible, en equipo, con alma y empezando por nuestros médicos que son la pieza fundamental de Cetaphil como lo es el Dr. Pepe Arana que siempre nos contagia de ciencia pero con mucha diversión y muy a su manera. También infinitas gracias a talentos que estuvieron en este proyecto pues gracias a ellos "podemos cantar en la regadera". Alter Maro Vame Farileo Santa Griega Kid Pistola EddyVansky Así que ábranle a la caliente, vemos en la regadera.   #DuchaAndFlow #Cetaphil #DuchaAndFlowxCetaphil #GenZMarketing #SkincareInnovation #TuFlowConCetaphil #DigitalStrategy #EmotionalBranding #YouthCulture #BrandedContent #SkincareWithSoul

“We have more than 500 bacterial species living on the surface of our skin – maintaining the diversity of these microorganisms, ensuring everyone is playing nicely in the skin sandbox, is central to controlling common inflammatory skin conditions.” Professor Adam Friedman, Chair of Dermatology at George Washington University and Co-Chair of Galderma’s Global Sensitive Skincare Faculty (GSSF), is interested in the skin’s microbiome – and how it affects sensitive skin. This fascination led him to become involved with the GSSF and its research efforts, including a recent study published in the Journal of Drugs and Dermatology. By investigating how imbalances in bacteria contribute to conditions like eczema, this study found that Cetaphil® Restoraderm moisturizer can help reduce the overgrowth of pathologic bacteria while supporting the growth of supportive bacteria, which in turn can create a healthy skin barrier. This study marks an important step in translating science into everyday solutions for those living with sensitive skin. #AdvancingDermatology #GSSF #SensitiveSkin

Last week, we celebrated the move of our U.S. Headquarters to Miami, positioning Galderma at the heart of a vibrant and thriving market for Injectable Aesthetics and Dermatological Skincare. Bringing industry leaders together in this dynamic hub marks a new chapter of growth, innovation, and connection. Thank you to all the visionary leaders who joined us to commemorate this milestone. Together, we’re building the future of skin health in a city that is a premium destination and trend-setter in areas closely aligned to our business. #AdvancingDermatology #SkinHealth #GaldermaGrowth Rodrick Miller Maria Dreyfus-Ulvert

We officially launched our new U.S. headquarters in Miami last night – a key milestone marking the establishment of our strategic presence in this vital market and deepening engagement with one of the world’s most vibrant dermatology communities. The event brought together civic leaders, customers, GAIN faculty, and healthcare professionals — alongside key influential voices, journalists, and colleagues — all united by a shared commitment to advancing skin health. With a warm welcome from the local community, we are proud to call Miami home and look forward to continuing to advance our category leadership in dermatology from the Magic City. #AdvancingDermatology #Miami

Our U.S. Vice President of Medical Affairs, Bill Andriopoulos, PhD, highlights the importance of collaboration and healthcare professional engagement to address remaining unmet needs in #AtopicDermatitis. Click below to read more insights from his article. #AdvancingDermatology #SkinScienceByGalderma

After six high-impact months, we’re pleased to share the numbers behind our continued growth momentum in a year full of opportunities. Galderma achieved a record-breaking 2.448 billion USD in net sales in the first half of 2025, an increase of 12.2% year-on-year at constant currency. Our growth across all product categories was driven by our strong commercial performance, new progress in innovation, and Galderma’s solid leadership in cutting-edge science and education across the dermatology spectrum. Highlights include the impactful launch and outstanding performance of our novel biologic for prurigo nodularis and atopic dermatitis. See full details of our H1 2025 performance here: https://lnkd.in/duzrEAmP #AdvancingDermatology #H1results #GALD #DermatologyPowerhouse

“You cannot paint everyone with the same brush.” Professor Ncoza Dlova is Head of Dermatology at the University of KwaZulu-Natal in South Africa – as well as a passionate advocate for greater inclusivity in dermatology. As a member of Galderma’s Global Sensitive Skincare Faculty (GSSF), she emphasizes the need to understand how geography, genetics and culture influence how sensitive skin manifests across populations. Through a global study involving 16,000 subjects worldwide, Professor Dlova and her GSSF colleagues uncovered striking variations – from stress-related sensitivity in China to symptoms of burning and tightness in India. Notably, they found that patients with darker skin tones often experience greater sensitivity. These insights are helping to shift dermatology away from a one-size-fits-all approach, toward more personalized solutions for individual consumers and patients. #AdvancingDermatology #GSSF #SensitiveSkin

Many of us can relate to the struggle of wanting to feel more comfortable in our own skin, but what if your skin itself was uncomfortable? For the 230 million atopic dermatitis patients worldwide, this could be their reality.    Find out more about the physical and mental impact of atopic dermatitis in this article, including insights from Dr. Chih-ho Hong: https://lnkd.in/eHZwVH_y

This week, we published new nine-month data on our Injectable Aesthetics portfolio in addressing facial changes linked to medication-driven weight loss – another step towards advancing evidence-based care.    Beyond this study, we’ve taken a wider look at how medication-driven weight loss is reshaping faces and what this means for the aesthetics landscape. We collaborated with global experts to define best practices and deepen our understanding of this phenomenon, leading the way so that clinicians can meet the needs of this emerging patient group.    Our comprehensive report brings together expert consensus and patient perspectives to support aesthetic practitioners in delivering personalized, patient-centered care.    Read the full report on our website: https://lnkd.in/gx7GJnKR

As the aesthetics community continues to adapt to the rise of medication-driven weight loss, new data is helping to shape the path forward. We’ve just announced nine-month results from our ongoing study exploring how our injectable aesthetics portfolio may help address the facial aesthetic changes after medication-driven weight loss. Find out more in our press release https://lnkd.in/eTCCC8kA #FacialAesthetics #AdvancingDermatology